InfoBionic, Inc.

Chelmsford, MA · Founded 2011 · Medtech · Private

Mobile cardiac telemetry platform for remote monitoring and virtual care delivery

Claim this profile

Follows are private to you and power your alerts

Updated · infobionic.ai

Sector
Medtech
Headquarters
Chelmsford, MA
Founded
2011
Latest Form D
$57.8M, Oct 2023
Total capital
$93.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$93.4M
6 Form D · last Oct 2023
37 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
16
8 pending · first 2016
Rank in peer group#138 of 1112

Capital timeline

201220142016201820202022FEDERAL ↑EQUITY ↓Cumulative $93.4M1st Form D$969K4th Form D$3M5th Form D$23.9M6th Form D$57.8M
201220142016201820202022FEDERAL ↑EQUITY ↓Cumulative $93.4M6th Form D$57.8M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$57.8M
  • Private capital raisedForm D · SEC · 5th filing$23.9M
  • Private capital raisedForm D · SEC · 4th filing$3M
  • Private capital raisedForm D · SEC · 3rd filing$6.6M
  • Private capital raisedForm D · SEC · 2nd filing$1.2M
  • Private capital raisedForm D · SEC · 1st filing$969K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#138 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • MICHAEL FAHEYResearcherExecutive OfficerLinked by 5 patents
  • Ravi KuppurajResearcherExecutive Officer, DirectorLinked by 3 patents
  • Adrian SteckelDirectorNamed in SEC Form D filings
  • Al WiegmanDirectorNamed in SEC Form D filings
  • Anna McNamaraExecutive OfficerNamed in SEC Form D filings
  • Brian SiskoDirectorNamed in SEC Form D filings
Show all 23 people
  • Caleb WinderDirectorNamed in SEC Form D filings
  • Carl BerkeDirectorNamed in SEC Form D filings
  • Chris StrasinskiExecutive OfficerNamed in SEC Form D filings
  • David MacCutcheonExecutive OfficerNamed in SEC Form D filings
  • Eric BooneExecutive OfficerNamed in SEC Form D filings
  • Gerardo IbarraExecutive Officer, DirectorNamed in SEC Form D filings
  • Hamid TabatabaieDirectorNamed in SEC Form D filings
  • Kiran RaoDirectorNamed in SEC Form D filings
  • Mustafa SagirugluExecutive OfficerNamed in SEC Form D filings
  • Nancy BriefsExecutive Officer, DirectorNamed in SEC Form D filings
  • Peter NoseworthyDirectorNamed in SEC Form D filings
  • Peter van der SluisExecutive OfficerNamed in SEC Form D filings
  • Philip LeoneExecutive OfficerNamed in SEC Form D filings
  • Serban GeorgescuExecutive OfficerNamed in SEC Form D filings
  • Shirley GeeDirectorNamed in SEC Form D filings
  • Steven WassermanExecutive OfficerNamed in SEC Form D filings
  • Stuart LongExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 16 granted of 24
  • PendingSystems And Methods For Hybrid Electrocardiography Monitoring TypesUSPTOApplication 18844274
  • GrantedRemote Health Monitoring SystemUSPTOUS 12,094,317
  • PendingSystems And Methods For Assessing Ecg Lead Signal QualityUSPTOApplication 18488219
Show all 24 patent records
  • ALBA-TECHNIC, LLCSimilar federal contract value in Medtech · null in contracts
  • INHERENT TARGETING, LLCSimilar federal contract value in Medtech · null in contracts
  • SOAIR, LLCSimilar federal contract value in Medtech · null in contracts
  • Leviant, Inc.Similar federal contract value in Medtech · null in contracts
  • NEOGENIS LABORATORIES, INC.Similar federal contract value in Medtech · null in contracts
  • 3FATES-XRAY, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .